A clinical trial on ayurvedic therapy in delayed and scanty menses
- Conditions
- Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Registration Number
- CTRI/2022/06/043068
- Lead Sponsor
- ational Institute of AyurvedaJaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Age of patient between 20-35 years, Married/unmarried patients suffering from any two of the following cardinal symptoms of ArtavaKshaya:
1-Yathochitakalaadarshanam -if the interval between 2 menstrual cycles exceeds more than 35 days.
2- Alpartavam â?? a) Duration of bleeding <3 days â?? score less than 25
in PBAC (Pictorial blood loss assessment chart).
b) Decrease in quantity of bleeding -score less than 20 in PBAC (Pictorial blood loss assessment chart).
3- YoniVedana - Pain during menstruation in internal genital organs.
1-Pregnancy, labor or breastfeeding within the past 3 months. 2-History of intake of oral contraceptive or ovulation inducing agent within the past 3 months. 3- Established endocrine disorders. 4- Interval between 2 consecutive menstrual cycles is more than 6 months. 5- Oligomenorrhea with hypermenorrhea. 6- Patient suffering from any uterine or pelvic pathology. 7- Patient with any malignancy or anatomical defect. 8- Patient suffering from any severe systemic disorders. 9-Intake of psychoactive drugs or antiepileptic drugs (valproic acid).10- Patient vaccinated against covid19 within last3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in classical triad of ArtavaKshaya assessed on the basis of Pictorial blood loss assessment chart and Visual Analogue Scale (VAS).Timepoint: Base line, follow up in 15 days
- Secondary Outcome Measures
Name Time Method 1- Safety of drugs assessed through LFT and RFT. <br/ ><br>2- Improvement in quality of lifeassessed through SF-36 questionnaire.Timepoint: 60 days